“The present circumstance has uncovered some structural weaknesses from the EU’s medicines source chain and also a significant dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides mentioned. She recommended that provide chain troubles be dealt with in an EU pharmaceutical technique expected to get la